P

Inventor

GOUT IVAN

GB12 patents
⚠️ This page may combine multiple inventors who share the name “GOUT IVAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LUDWIG INST CANCER RES

6 patents
US5824492AOct 20, 1998

Polypeptides having kinase activity, their preparation and use

LUDWIG INST CANCER RES127 citations96
US6274327B1Aug 14, 2001

Polypeptides having kinase activity, their preparation and use

LUDWIG INST CANCER RES40 citations90
US5846824ADec 8, 1998

Polypeptides having kinase activity, their preparation and use

LUDWIG INST CANCER RES43 citations90
US7335467B2Feb 26, 2008

Breast cancer antigens

LUDWIG INST CANCER RES4 citations62
US7422849B1Sep 9, 2008

Method for determining expression of a PI3 kinase gene

LUDWIG INST CANCER RES5 citations60
US6830909B1Dec 14, 2004

Identification and functional characterization of a novel ribosomal S6 protein kinase

LUDWIG INST CANCER RES3 citations56

RITTER GERD

2 patents
US8603474B2Dec 10, 2013

Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy

RITTER GERD27 citations89
US9045533B2Jun 2, 2015

Membrane transporter NaPi2b (SCL34A2) epitope antibodies

RITTER GERD3 citations59

LUDWIG INST FOR CANCER RES LTD

2 patents
US9701755B2Jul 11, 2017

Membrane transporter NaPi2b (SCL34A2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy

LUDWIG INST FOR CANCER RES LTD0 citations49
US7998718B2Aug 16, 2011

Identification and functional characterization of a novel ribosomal S6 protein kinase

LUDWIG INST FOR CANCER RES LTD0 citations45

INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS NAT ACADEMY OF SCIENCE OF UKRANE

1 patent
US10385138B2Aug 20, 2019

Antibodies directed to membrane transporter NaP12b (SLC34A2) and uses thereof in cancer therapy

INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS NAT ACADEMY OF SCIENCE OF UKRANE0 citations42

NEMAZANYY IVAN

1 patent
US8669347B2Mar 11, 2014

Truncated variant of the mammalian target for rapamycin (MTOR) protein

NEMAZANYY IVAN0 citations34